• CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).

Duration: October 1, 2009 to present

General Issues: Health Issues, Medicare/Medicaid, Budget/Appropriations, Medical/Disease Research/Clinical Labs, Science/Technology

Spending: about $3,590,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2009: U.S. Senate, House of Representatives, Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Office of Science & Technology Policy (OSTP), Office of Science & Technology Policy (OSTP),, U.S. Senate,, Centers For Medicare and Medicaid Services (CMS),, Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS), Agency for Health Care Policy & Research, Natl Institutes of Health (NIH),, Natl Institute of Standards & Technology (NIST)